UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 103

Sortiert nach

Activity of Elvitegravir, a Once-Daily Integrase Inhibitor, against Resistant HIV Type 1: Results of a Phase 2, Randomized, Controlled, Dose-Ranging Clinical Trial

The Journal of infectious diseases, 2010-03, Vol.201 (6), p.814-822

2010

Link zum Volltext

Verfügbarkeit prüfen

Association of low level viremia with inflammation and mortality in HIV-infected adults

PloS one, 2011-11, Vol.6 (11), p.e26320-e26320

2011

Link zum Volltext

Verfügbarkeit prüfen

Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease following Different Protease Inhibitor Treatments

Journal of Virology, 2003-04, Vol.77 (8), p.4836-4847

2003

Link zum Volltext

Verfügbarkeit prüfen

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

PloS one, 2009-05, Vol.4 (5), p.e5575-e5575

2009

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance

The Journal of infectious diseases, 2005-08, Vol.192 (3), p.456-465

2005

Link zum Volltext

Verfügbarkeit prüfen

Antiviral Activity of Lamivudine in Salvage Therapy for Multidrug-Resistant HIV-1 Infection

Clinical infectious diseases, 2005-07, Vol.41 (2), p.236-242

2005

Link zum Volltext

Verfügbarkeit prüfen

The evolution of HIV treatment guidelines: Current state-of-the-art of ART

Antiviral research, 2010, Vol.85 (1), p.241-244

Zolopa, Andrew R.

2010

Link zum Volltext

Verfügbarkeit prüfen

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort

Journal of acquired immune deficiency syndromes (1999), 2010-11, Vol.55 (3), p.316

2010

Link zum Volltext

Verfügbarkeit prüfen

Concerns Regarding a Randomized Study of the Timing of Antiretroviral Therapy in Zimbabweans with AIDS and Acute Cryptococcal Meningitis

Clinical infectious diseases, 2010-10, Vol.51 (8), p.984-985

2010

Link zum Volltext

Verfügbarkeit prüfen

Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV

AIDS (London), 2021-10, Vol.35 (12), p.1957-1965

2021

Link zum Volltext

Verfügbarkeit prüfen

Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations

Antimicrobial Agents and Chemotherapy, 2009-11, Vol.53 (11), p.4869-4878

2009

Link zum Volltext

Verfügbarkeit prüfen

Lack of Detectable Human Immunodeficiency Virus Type 1 Superinfection during 1072 Person-Years of Observation

The Journal of infectious diseases, 2003-08, Vol.188 (3), p.397-405

2003

Link zum Volltext

Verfügbarkeit prüfen

Low Baseline CD4+Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy Initiation

Clinical infectious diseases, 2013-11, Vol.57 (10), p.1483-1488

2013

Link zum Volltext

Verfügbarkeit prüfen

Blood (1 → 3)-β-D-Glucan as a Diagnostic Test for HIV-Related Pneumocystis jirovecii Pneumonia

Clinical infectious diseases, 2011-07, Vol.53 (2), p.197-202

2011

Link zum Volltext

Verfügbarkeit prüfen

Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy

Nephrology, dialysis, transplantation, 2015-10, Vol.30 (10), p.1734-1740

2015

Link zum Volltext

Verfügbarkeit prüfen

Incorporating Drug‐Resistance Measurements into the Clinical Management of HIV‐1 Infection

The Journal of infectious diseases, 2006-09, Vol.194 (Supplement-1), p.S59-S64

Zolopa, Andrew R.

2006

Link zum Volltext

Verfügbarkeit prüfen

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS

AIDS (London), 2001-06, Vol.15 (9), p.1181-1183

2001

Link zum Volltext

Verfügbarkeit prüfen

Effect of Concomitantly Administered Rifampin on the Pharmacokinetics and Safety of Atazanavir Administered Twice Daily

Antimicrobial Agents and Chemotherapy, 2007-09, Vol.51 (9), p.3104-3110

2007

Link zum Volltext

Verfügbarkeit prüfen

International Cohort Analysis of the Antiviral Activities of Zidovudine and Tenofovir in the Presence of the K65R Mutation in Reverse Transcriptase

Antimicrobial Agents and Chemotherapy, 2010-04, Vol.54 (4), p.1520-1525

2010

Link zum Volltext

Verfügbarkeit prüfen

Evolution of HIV treatment guidelines in high- and low-income countries: Converging recommendations

Antiviral research, 2014-03, Vol.103, p.88-93

2014

Link zum Volltext

Verfügbarkeit prüfen

Elevated Interleukin 8 and T-Helper 1 and T-Helper 17 Cytokine Levels Prior to Antiretroviral Therapy in Participants Who Developed Immune Reconstitution Inflammatory Syndrome During ACTG A5164

The Journal of infectious diseases, 2012-12, Vol.206 (11), p.1715-1723

2012

Link zum Volltext

Verfügbarkeit prüfen

Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks

Open forum infectious diseases, 2023-03, Vol.10 (3), p.ofad101-ofad101

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Enfuvirtide in Combination with Darunavir-Ritonavir and an Optimized Background Regimen in Treatment-Experienced Human Immunodeficiency Virus-Infected Patients: the Below the Level of Quantification Study

Antimicrobial Agents and Chemotherapy, 2008-12, Vol.52 (12), p.4315-4319

2008

Link zum Volltext

Verfügbarkeit prüfen

Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms

AIDS (London), 2013-03, Vol.27 (6), p.967-972

2013

Link zum Volltext

Verfügbarkeit prüfen

Evolution of Primary Protease Inhibitor Resistance Mutations during Protease Inhibitor Salvage Therapy

Antimicrobial Agents and Chemotherapy, 2002-04, Vol.46 (4), p.1086-1092

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(99)
Buchkapitel
(4)

Sprache

Englisch
(103)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Humans
(81)
Science & Technology
(77)
Life Sciences & Biomedicine
(74)
Infectious Diseases
(64)
Biological And Medical Sciences
(60)
Medical Sciences
(57)
Adult
(53)
Male
(51)
Female
(47)
Hiv Infections - Drug Therapy
(47)
Immunology
(42)
Hiv
(41)
Human Immunodeficiency Virus
(37)
Human Viral Diseases
(36)
Viral Diseases
(36)
Virology
(36)
Microbiology
(35)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(34)
Aids/hiv
(31)
Middle Aged
(29)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Activity of Elvitegravir, a Once-Daily Integrase Inhibitor, against Resistant HIV Type 1: Results of a Phase 2, Randomized, Controlled, Dose-Ranging Clinical Trial

Association of low level viremia with inflammation and mortality in HIV-infected adults

Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease following Different Protease Inhibitor Treatments

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance

Antiviral Activity of Lamivudine in Salvage Therapy for Multidrug-Resistant HIV-1 Infection

The evolution of HIV treatment guidelines: Current state-of-the-art of ART

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort

Concerns Regarding a Randomized Study of the Timing of Antiretroviral Therapy in Zimbabweans with AIDS and Acute Cryptococcal Meningitis

Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV

Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations

Lack of Detectable Human Immunodeficiency Virus Type 1 Superinfection during 1072 Person-Years of Observation

Low Baseline CD4+Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy Initiation

Blood (1 → 3)-β-D-Glucan as a Diagnostic Test for HIV-Related Pneumocystis jirovecii Pneumonia

Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy

Incorporating Drug‐Resistance Measurements into the Clinical Management of HIV‐1 Infection

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS

Effect of Concomitantly Administered Rifampin on the Pharmacokinetics and Safety of Atazanavir Administered Twice Daily

International Cohort Analysis of the Antiviral Activities of Zidovudine and Tenofovir in the Presence of the K65R Mutation in Reverse Transcriptase

Evolution of HIV treatment guidelines in high- and low-income countries: Converging recommendations

Elevated Interleukin 8 and T-Helper 1 and T-Helper 17 Cytokine Levels Prior to Antiretroviral Therapy in Participants Who Developed Immune Reconstitution Inflammatory Syndrome During ACTG A5164

Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks

Safety and Efficacy of Enfuvirtide in Combination with Darunavir-Ritonavir and an Optimized Background Regimen in Treatment-Experienced Human Immunodeficiency Virus-Infected Patients: the Below the Level of Quantification Study

Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms

Evolution of Primary Protease Inhibitor Resistance Mutations during Protease Inhibitor Salvage Therapy

Suchergebnisse filtern